IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Revenue: ₹23,191 Mil (TTM As of Mar. 2026)


NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
63 GF Score
Price ₹147.21
GF Value ₹93.87
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Revenue?

IOL Chemicals And Pharmaceuticals NSE:IOLCP +1.32% 63 Revenue is ₹23,191 Mil as of Mar. 2026. GuruFocus rates NSE:IOLCP with a GF Score™ of 63/100 and a GF Value™ of ₹93.87 (Significantly Overvalued). The stock has 5 warning signs investors should review.

IOL Chemicals And Pharmaceuticals's revenue for the three months ended in Mar. 2026 was ₹6,195 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹23,191 Mil. IOL Chemicals And Pharmaceuticals's Revenue per Share for the three months ended in Mar. 2026 was ₹21.09. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹79.01.

During the past 12 months, the average Revenue per Share Growth Rate of IOL Chemicals And Pharmaceuticals was 11.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 2.00% per year. During the past 10 years, the average Revenue per Share Growth Rate was 13.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, IOL Chemicals And Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 38.80% per year. The lowest was -19.10% per year. And the median was 2.70% per year.


IOL Chemicals And Pharmaceuticals  (NSE:IOLCP) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


IOL Chemicals And Pharmaceuticals Revenue Related Terms


IOL Chemicals And Pharmaceuticals Revenue Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Revenue Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21,683.70 22,016.90 21,189.60 20,792.10 23,190.60

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,277.80 5,516.90 5,675.30 5,803.90 6,194.50

NSE:IOLCP vs ZTS, UTHR: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Revenue distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Revenue falls into.


NSE:IOLCP
63GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹23,191 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of ₹23,191 Mil mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Revenue of ₹23,191 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on IOL Chemicals And Pharmaceuticals and its competitors.
Is IOL Chemicals And Pharmaceuticals' Revenue too high?
IOL Chemicals And Pharmaceuticals' current Revenue is ₹23,191 Mil. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Revenue compare to ZTS and UTHR?
IOL Chemicals And Pharmaceuticals' Revenue of ₹23,191 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. IOL Chemicals And Pharmaceuticals's current Revenue is ₹23,191 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.87, compared to a current price of ₹147.21 — trading 56.8% above its estimated fair value. The current Revenue is ₹23,191 Mil. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Revenue is ₹23,191 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹147.21 is trading 56.8% above its estimated GF Value™ of ₹93.87. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Revenue: ₹23,191 Mil
  • GF Value™: ₹93.87 vs. price of ₹147.21 (56.8% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
63GF Score

Get the complete analysis for NSE:IOLCP

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹147.21
Price
₹93.87
GF Value